Cadence Bank boosted its holdings in Novo Nordisk A/S (NYSE:NVO – Free Report) by 100.0% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,182 shares of the company’s stock after acquiring an additional 1,591 shares during the quarter. Cadence Bank’s […]
Cantor Fitzgerald restated their overweight rating on shares of Novo Nordisk A/S (NYSE:NVO – Free Report) in a research note published on Tuesday morning, Benzinga reports. The brokerage currently has a $140.00 target price on the stock. A number of other analysts have also commented on the company. UBS Group began coverage on Novo Nordisk […]
Visionary Wealth Advisors bought a new stake in Novo Nordisk A/S (NYSE:NVO – Free Report) during the 3rd quarter, HoldingsChannel reports. The fund bought 2,294 shares of the company’s stock, valued at approximately $209,000. Several other hedge funds and other institutional investors have also made changes to their positions in NVO. Copeland Capital Management LLC […]
Visionary Wealth Advisors bought a new stake in Novo Nordisk A/S (NYSE:NVO – Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 2,294 shares of the company’s stock, valued at approximately $209,000. A number of other hedge funds and other institutional […]
Visionary Wealth Advisors purchased a new position in Novo Nordisk A/S (NYSE:NVO – Free Report) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 2,294 shares of the company’s stock, valued at approximately $209,000. Several other institutional investors and hedge funds have also […]